HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Data supplement Submit an eLetter View responses Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Related articles in BJP Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by FURUKAWA, T. A. Articles by CHURCHILL, R. Search for Related Content PubMed PubMed Citation Articles by FURUKAWA, T. A. Articles by CHURCHILL, R.

Psychotherapy plus antidepressant for panic disorder with or without agoraphobia

Systematic review

Department of Psychiatry and Cognitive–Behavioural Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

RACHEL CHURCHILL, MSc, PhD

Cochrane Collaboration Depression, Anxiety and Neurosis Review Group, Health Services Research Department, Institute of Psychiatry, London, UK

Correspondence: Professor Toshi A. Furukawa, Department of Psychiatry and Cognitive–Behavioural Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya City University Medical School, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan. Tel: +81 52 853 8271; fax: +81 52 852 0837; e-mail: furukawa{at}med.nagoya-cu.ac.jp

Declaration of interest T.A.F. has received research grants and fees for speaking from several pharmaceutical companies. These companies did not provide funding for the current study (see Acknowledgements).

Background Panic disorder can be treated with psychotherapy, pharmacotherapy or a combination of both.

Aims To summarise the evidence concerning the short- and long-term benefits and adverse effects of a combination of psychotherapy and antidepressanttreatment.

Method Meta-analyses and meta-regressions were undertaken using data from all relevant randomised controlled trials identified by a comprehensive literature search. The primary outcome was relative risk (RR) of response.

Results We identified 23 randomised comparisons (21 trials involving a total of 1709 patients). In the acute-phase treatment, the combined therapy was superior to antidepressant pharmacotherapy (RR=1.24,95% CI1.02–1.52) or psychotherapy (RR=1.16,95% CI1.03–1.30). After termination of the acute-phase treatment, the combined therapy was more effective than pharmacotherapy alone (RR=1.61,95% CI1.23–2.11) and was as effective as psychotherapy (RR=0.96, 95% CI 0.79–1.16).

Conclusions Either combined therapy or psychotherapy alone may be chosen as first-line treatment for panic disorder with or without agoraphobia, depending on the patient’s preferences.

Related articles in BJP:

PETER TYRER
BJP 2006 188: 400. [Full Text]  

This article has been cited by other articles:

				G. Foldes-Busque, A. Marchand, and P. Landry L'identification et traitement du trouble panique avec ou sans agoraphobie: Mise a jour Can Fam Physician, October 1, 2007; 53(10): 1686 - 1693. [Abstract] [Full Text] [PDF]

				K. Mitte Review: psychotherapy plus antidepressant therapy increases response rate in people with panic disorder more than either treatment alone. Evid. Based Ment. Health, November 1, 2006; 9(4): 98 - 98. [Full Text] [PDF]

eLetters: